Skip to main content
Shenzhen Chipscreen Biosciences Co., Ltd. logo

Shenzhen Chipscreen Biosciences Co., Ltd. — Investor Relations & Filings

Ticker · 688321 ISIN · CNE100003LW0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 967 across all filing types
Latest filing 2025-04-25 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688321

About Shenzhen Chipscreen Biosciences Co., Ltd.

https://www.chipscreen.com/en/

Shenzhen Chipscreen Biosciences Co., Ltd. specializes in the discovery and development of original small molecule innovative drugs. The company leverages its proprietary chemical genomics-based drug discovery and early evaluation platform to address unmet medical needs in oncology, metabolic diseases, and autoimmune disorders. Its portfolio includes Chidamide (Epidaza), a selective histone deacetylase (HDAC) inhibitor approved for peripheral T-cell lymphoma and advanced breast cancer, and Chiglitazar (Bilessyl), a novel PPAR pan-agonist for type 2 diabetes. Chipscreen Biosciences maintains an integrated R&D system covering drug discovery, clinical development, and commercialization, focusing on molecular mechanisms and translational medicine to provide novel therapeutic solutions.

Recent filings

Filing Released Lang Actions
2024年内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year 2024 by Shenzhen Microchip Biotechnology Co., Ltd. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2024, including financial reporting internal control and non-financial reporting internal control. The document contains detailed descriptions of the evaluation scope, standards for identifying control deficiencies, and conclusions on the effectiveness of internal controls. It is a standalone report focused on internal control evaluation rather than a full annual report or audit report. The content aligns with an Audit Report / Information filing, which includes audit results and applied accounting principles related to internal controls but is not a full annual report (10-K). The document length is under 5,000 characters but contains substantive evaluation content, so it is not merely an announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2024
2025-04-25 Chinese
第三届董事会审计委员会2024年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2024年度履职情况报告" (2024 Annual Performance Report) of the Audit Committee of the Board of Directors of Shenzhen Microcore Biotechnology Co., Ltd. It details the composition of the audit committee, meetings held during 2024, supervision and evaluation of external audit firms, internal audit guidance, internal control system supervision, and an overall evaluation of the committee's work. The content focuses on the audit committee's activities and oversight rather than presenting standalone audit opinions or financial statements. The document length is 1841 characters, which is relatively short and more consistent with a committee report rather than a full audit report or annual report. It is not a certification or a brief announcement but a detailed committee report on audit-related activities. This fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and related information excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2024
2025-04-25 Chinese
2024年度独立董事述职报告（罗勇根）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2024 for Shenzhen Microchip Biotechnology Co., Ltd. It details the independent director's activities, attendance at board and committee meetings, oversight of financial reports, and governance matters. The content focuses on the independent director's duties, evaluations, and opinions on company governance and financial reporting, rather than presenting full financial statements or audit results. It is a detailed report on board/management information, specifically about the independent director's role and activities. It is not an annual report, audit report, or earnings release. It is not a short announcement or certification but a substantive report on management/board activities. Therefore, the best fitting category is Board/Management Information (MANG). The document length (4334 characters) is sufficient for a detailed report but not a full financial report. Confidence is high given the clear focus on independent director duties and board activities.
2025-04-25 Chinese
关于本次向特定对象发行A股股票不存在直接或通过利益相关方向参与认购的投资者提供财务资助或补偿事宜的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen Microchip Biotechnology Co., Ltd. regarding a specific issuance of A shares to particular investors. It explicitly states that there is no financial assistance or compensation provided to investors related to this issuance. The content focuses on capital issuance details and compliance with regulatory requirements about the share issuance. The document length is short (496 characters) and it is a formal announcement about a capital raising event, not a full financial report or detailed analysis. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2025-04-25 Chinese
关于续聘2025年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the audit firm KPMG Huazhen for the 2025 fiscal year. It details the audit firm's background, qualifications, independence, and the approval process by the board and shareholders. There are no actual financial statements or audit reports included, only information about the audit firm and the decision to continue their engagement. The document length is relatively short (2596 characters) and it serves as a formal announcement rather than the audit report itself. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and related information about audit firms and their appointments, excluding full annual reports. FY 2025
2025-04-25 Chinese
2024年度环境、社会及公司治理（ESG）报告
Environmental & Social Information Classification · 100% confidence The document is titled "2024 年度 环境、社会及公司治理(ESG) 报告" which translates to "2024 Environmental, Social and Governance (ESG) Report". It covers extensive ESG topics including environmental management, social responsibility, governance structure, and sustainability performance. The content includes detailed sections on ESG governance, management mechanisms, materiality assessments, stakeholder engagement, and sustainability achievements. The document is comprehensive and contains substantive information on the company's ESG performance and practices for the year 2024. It is not a brief announcement or a certification letter, nor is it a financial report or earnings release. The document fits the definition of an Environmental & Social Information report, detailing the company's ESG factors and performance.
2025-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.